Literature DB >> 1371198

Inhibition of liver, kidney, and intestine regeneration by rapamycin.

A Francavilla1, T E Starzl, C Scotti, G Carrieri, A Azzarone, Q H Zeng, K A Porter, S L Schreiber.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1371198      PMCID： PMC2979306          DOI： 10.1097/00007890-199202010-00045

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  26 in total

1.  In vitro and in vivo evaluation of US-NCI compounds in human tumor xenografts.

Authors:  H H Fiebig; D P Berger; B R Winterhalter; J Plowman
Journal:  Cancer Treat Rev       Date:  1990-09       Impact factor: 12.111

2.  Transplantation.

Authors:  T E Starzl; J J Fung
Journal:  JAMA       Date:  1990-05-16       Impact factor: 56.272

3.  Cyclosporine A augments the regenerative response after partial hepatectomy in the rat.

Authors:  D Kahn; H S Lai; H Romovacek; L Makowka; D Van Thiel; T E Starzl
Journal:  Transplant Proc       Date:  1988-06       Impact factor: 1.066

4.  Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies.

Authors:  T E Starzl; S Todo; A Tzakis; L Podesta; L Mieles; A Demetris; L Teperman; R Selby; W Stevenson; A Stieber
Journal:  Ann Surg       Date:  1989-09       Impact factor: 12.969

5.  Cyclosporin A stimulates proliferation of the liver cells after partial hepatectomy in rats.

Authors:  Y I Kim; R Y Calne; N Nagasue
Journal:  Surg Gynecol Obstet       Date:  1988-04

6.  Augmentation of rat liver regeneration by FK 506 compared with cyclosporin.

Authors:  A Francavilla; M Barone; S Todo; Q Zeng; K A Porter; T E Starzl
Journal:  Lancet       Date:  1989-11-25       Impact factor: 79.321

7.  A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin.

Authors:  J J Siekierka; S H Hung; M Poe; C S Lin; N H Sigal
Journal:  Nature       Date:  1989-10-26       Impact factor: 49.962

8.  Human brain tumor xenografts in nude mice as a chemotherapy model.

Authors:  D P Houchens; A A Ovejera; S M Riblet; D E Slagel
Journal:  Eur J Cancer Clin Oncol       Date:  1983-06

9.  The immunochemical distribution of cyclophilin in normal mammalian tissues.

Authors:  W H Marks; M W Harding; R Handschumacher; C Marks; M I Lorber
Journal:  Transplantation       Date:  1991-08       Impact factor: 4.939

10.  The refolding of urea-denatured ribonuclease A is catalyzed by peptidyl-prolyl cis-trans isomerase.

Authors:  G Fischer; H Bang
Journal:  Biochim Biophys Acta       Date:  1985-03-22
View more
  15 in total

1.  Effects on in vivo and in vitro hepatocyte proliferation of methylprednisolone, azathioprine, mycophenolic acid, mizoribine, and prostaglandin E1.

Authors:  A Azzarone; A Francavilla; G Carrieri; A Gasbarrini; C Scotti-Foglieni; S Fagiuoli; U Cillo; Q H Zeng; T E Starzl
Journal:  Transplant Proc       Date:  1992-12       Impact factor: 1.066

2.  Rapamycin Inhibition of mTOR Reduces Levels of the Na+/H+ Exchanger 3 in Intestines of Mice and Humans, Leading to Diarrhea.

Authors:  Jun Yang; Xiaofeng Zhao; Archana Patel; Rachana Potru; Sadra Azizi-Ghannad; Michael Dolinger; James Cao; Catherine Bartholomew; Joseph Mazurkiewicz; David Conti; David Jones; Yunfei Huang; Xinjun Cindy Zhu
Journal:  Gastroenterology       Date:  2015-03-30       Impact factor: 22.682

3.  A fresh look at augmenter of liver regeneration in rats.

Authors:  C R Gandhi; R Kuddus; V M Subbotin; J Prelich; N Murase; A S Rao; M A Nalesnik; S C Watkins; A DeLeo; M Trucco; T E Starzl
Journal:  Hepatology       Date:  1999-05       Impact factor: 17.425

4.  8-pCPT-cGMP prevents mitochondrial depolarization and improves the outcome of steatotic partial liver transplantation.

Authors:  Qinlong Liu; Hasibur Rehman; Yasodha Krishnasamy; John J Lemasters; Zhi Zhong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-06-15

5.  Hepatic growth effects of methylprednisolone, azathioprine, mycophenolic acid, and mizoribine.

Authors:  A Azzarone; A Francavilla; Q H Zeng; T E Starz
Journal:  Transplantation       Date:  1993-07       Impact factor: 4.939

6.  mTOR signaling in liver regeneration: Rapamycin combined with growth factor treatment.

Authors:  Suomi Mg Fouraschen; Petra E de Ruiter; Jaap Kwekkeboom; Ron Wf de Bruin; Geert Kazemier; Herold J Metselaar; Hugo W Tilanus; Luc Jw van der Laan; Jeroen de Jonge
Journal:  World J Transplant       Date:  2013-09-24

7.  Effects of rapamycin on cultured hepatocyte proliferation and gene expression.

Authors:  A Francavilla; B I Carr; T E Starzl; A Azzarone; G Carrieri; Q H Zeng
Journal:  Hepatology       Date:  1992-05       Impact factor: 17.425

8.  The physiology and pathophysiology of rapamycin resistance: implications for cancer.

Authors:  Philip A Gruppuso; Joan M Boylan; Jennifer A Sanders
Journal:  Cell Cycle       Date:  2011-04-01       Impact factor: 4.534

9.  Portacaval shunt causes apoptosis and liver atrophy in rats despite increases in endogenous levels of major hepatic growth factors.

Authors:  Chandrashekhar R Gandhi; Noriko Murase; Vladimir M Subbotin; Tadahiro Uemura; Michael Nalesnik; Anthony J Demetris; John J Fung; Thomas E Starzl
Journal:  J Hepatol       Date:  2002-09       Impact factor: 25.083

10.  Oral administration of rapamycin and cyclosporine differentially alter intestinal function in rabbits.

Authors:  V C Dias; K L Madsen; K E Mulder; M Keelan; R W Yatscoff; A B Thomson
Journal:  Dig Dis Sci       Date:  1998-10       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.